Fate Therapeutics Inc (FATE)
4.06
-0.04
(-0.98%)
USD |
NASDAQ |
May 03, 16:00
4.06
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 13.93M |
June 30, 2019 | 14.92M |
March 31, 2019 | 14.90M |
December 31, 2018 | 14.88M |
September 30, 2018 | 14.86M |
June 30, 2018 | 14.85M |
Date | Value |
---|---|
March 31, 2018 | 14.83M |
December 31, 2017 | 14.81M |
September 30, 2017 | 14.79M |
June 30, 2017 | 6.676M |
March 31, 2017 | 8.701M |
December 31, 2016 | 10.69M |
September 30, 2016 | 12.64M |
June 30, 2016 | 14.54M |
March 31, 2016 | 16.40M |
December 31, 2015 | 18.24M |
September 30, 2015 | 19.13M |
June 30, 2015 | 19.70M |
March 31, 2015 | 19.67M |
December 31, 2014 | 19.61M |
September 30, 2014 | 10.00M |
June 30, 2014 | 0.746M |
March 31, 2014 | 1.24M |
December 31, 2013 | 1.732M |
September 30, 2013 | 25.70M |
June 30, 2013 | 2.708M |
March 31, 2013 | 0.00 |
December 31, 2012 | 3.673M |
September 30, 2012 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
14.92M
Maximum
Jun 2019
1.518M
Average
--
Median
Dec 2019
Total Long Term Debt (Quarterly) Benchmarks
Amicus Therapeutics Inc | 387.86M |
Sarepta Therapeutics Inc | 1.239B |
ADMA Biologics Inc | 130.59M |
Ocular Therapeutix Inc | 74.92M |
Viking Therapeutics Inc | -- |